LOGIN  |  REGISTER
Chimerix
C4 Therapeutics

Community Health Systems to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 14, 2025 | Last Trade: US$2.76 0.04 -1.43

FRANKLIN, Tenn. / May 14, 2025 / Business Wire / Community Health Systems, Inc. (NYSE:CYH) today announced that management will participate in the 2025 RBC Capital Markets Global Healthcare Conference to be held May 20-21, 2025, in New York.

The Company will host a fireside chat presentation on Wednesday, May 21, 2025, at 2:05 p.m. ET, 1:05 p.m. CT. The fireside chat presentation will be available to investors via a live audio webcast. A link to the broadcast can be found at the investor relations section of the Company’s website, www.chs.net, and a replay will be available using that same link.

About Community Health Systems, Inc.

Community Health Systems, Inc. is one of the nation’s largest healthcare companies. The Company’s affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 36 distinct markets across 14 states. As of April 23, 2025, the Company’s subsidiaries own or lease 71 affiliated hospitals with more than 10,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” More information about the Company can be found on its website at www.chs.net.

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page